UnitedHealth Group Incorporated $UNH Shares Sold by Quent Capital LLC

Quent Capital LLC lowered its position in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 10.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,645 shares of the healthcare conglomerate’s stock after selling 436 shares during the quarter. Quent Capital LLC’s holdings in UnitedHealth Group were worth $1,137,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Future Financial Wealth Managment LLC boosted its holdings in UnitedHealth Group by 164.9% in the second quarter. Future Financial Wealth Managment LLC now owns 1,486 shares of the healthcare conglomerate’s stock valued at $464,000 after acquiring an additional 925 shares during the last quarter. Hennessy Advisors Inc. purchased a new position in UnitedHealth Group in the second quarter valued at about $109,000. Ameriflex Group Inc. raised its position in UnitedHealth Group by 5.0% in the second quarter. Ameriflex Group Inc. now owns 1,938 shares of the healthcare conglomerate’s stock valued at $587,000 after purchasing an additional 92 shares during the period. ZWJ Investment Counsel Inc. raised its position in UnitedHealth Group by 1.8% in the second quarter. ZWJ Investment Counsel Inc. now owns 3,270 shares of the healthcare conglomerate’s stock valued at $1,020,000 after purchasing an additional 59 shares during the period. Finally, Successful Portfolios LLC raised its position in UnitedHealth Group by 19.7% in the second quarter. Successful Portfolios LLC now owns 1,311 shares of the healthcare conglomerate’s stock valued at $409,000 after purchasing an additional 216 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have commented on UNH. Bank of America raised their price objective on UnitedHealth Group from $290.00 to $325.00 and gave the company a “neutral” rating in a research report on Monday, August 18th. Royal Bank Of Canada dropped their target price on UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 30th. Morgan Stanley lifted their target price on UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a research report on Friday, September 12th. Truist Financial lifted their target price on UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a research report on Tuesday, September 9th. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of UnitedHealth Group in a research report on Saturday, September 27th. Sixteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and four have given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $358.95.

Read Our Latest Research Report on UnitedHealth Group

UnitedHealth Group Stock Up 1.8%

Shares of UnitedHealth Group stock opened at $360.17 on Friday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The business has a 50-day moving average price of $307.84 and a 200 day moving average price of $355.58. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The firm has a market cap of $326.20 billion, a P/E ratio of 15.61, a P/E/G ratio of 2.30 and a beta of 0.47.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same quarter in the previous year, the firm earned $6.80 earnings per share. The business’s revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s payout ratio is presently 38.30%.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.